Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II trial of recombinant soluble human tissue factor for mandibular bone consolidation after orthognathic surgery
2005-001885-14Phase 2Completed
- Sponsor
- Henogen
- Start
- Aug 2005
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of recombinant soluble human tissue factor in mandibular defect and Abnormal wound healing (2 arms), sponsored by Henogen. Primary endpoints: Mandible bone consolidation efficacy, Safety of local mandibular placement and 1 more. Started Aug 2005; status: completed.
02
Drugs
recombinant soluble human tissue factor
03
Conditions
mandibular defectAbnormal wound healing
Beyond the preview
Go deeper on 2005-001885-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001885-14.